Belbuca and Panic attacks - a phase IV clinical study of FDA data

Summary:

Panic attacks is reported as a side effect among people who take Belbuca (buprenorphine hydrochloride), especially for people who are female, 40-49 old, have been taking the drug for 1 - 2 years also take Vitamin D3, and have Hypoparathyroidism.

The phase IV clinical study analyzes which people have Panic attacks when taking Belbuca. It is created by eHealthMe based on reports of 2,994 people who have side effects when taking Belbuca from the FDA, and is updated regularly.

What is Belbuca?

Belbuca has active ingredients of buprenorphine hydrochloride. eHealthMe is studying from 3,022 Belbuca users. Check the latest studies of Belbuca.

What is Panic attacks?

Panic attacks is found to be associated with 2,606 drugs and 2,065 conditions by eHealthMe. Check the latest studies of Panic attacks.

On Oct, 11, 2025

2,994 people reported to have side effects when taking Belbuca.
Among them, 11 people (0.37%) have Panic attacks.

Among these 11 people:

How long have people been on Belbuca when they have Panic attacks? *

What is the gender of people who have Panic attacks when taking Belbuca? *

female: 87.5 %
male: 12.5 %

What is the age of people who have Panic attacks when taking Belbuca? *

What are other drugs people take besides Belbuca? *

What are other side effects people have besides Panic attacks? *

Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 4 people, 36.36%
Head Injury: 4 people, 36.36%
Skin Discoloration - Bluish (bluish colour of skin): 4 people, 36.36%
Procedural Complication: 4 people, 36.36%
Blood Calcium Decreased: 4 people, 36.36%
Broken Bone: 4 people, 36.36%
Hypocalcaemia (levels of calcium in blood serum are abnormally low): 4 people, 36.36%
Kidney Stones: 4 people, 36.36%
Tooth Loss: 3 people, 27.27%
Tooth Fracture: 3 people, 27.27%

What are the existing conditions these people have? *

Pain: 4 people, 36.36%
Hypoparathyroidism (inadequate secretion of parathyroid hormone resulting in abnormally low levels of calcium in the blood): 4 people, 36.36%
Stress And Anxiety: 1 person, 9.09%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 9.09%
Musculoskeletal Discomfort (discomfort in the body's muscles, joints, tendons, ligaments and nerves): 1 person, 9.09%
Insomnia (sleeplessness): 1 person, 9.09%
High Blood Pressure: 1 person, 9.09%
Depression: 1 person, 9.09%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 9.09%
Constipation: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Belbuca and have Panic attacks?

- Check whether Panic attacks is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Belbuca:

Belbuca (3,022 reports)

Panic attacks treatments and more:

Panic attacks (65,701 reports)

Browse all side effects of Belbuca:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Panic attacks:

Panic attacks (2,606 drugs)

Browse all the conditions that are associated with Panic attacks:

Panic attacks (2,065 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on buprenorphine hydrochloride (the active ingredients of Belbuca) and Belbuca (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.